These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29308648)

  • 1. Static and Dynamic Permeability Assay for Hydrophilic Small Molecules Using a Planar Droplet Interface Bilayer.
    Lee Y; Lee HR; Kim K; Choi SQ
    Anal Chem; 2018 Feb; 90(3):1660-1667. PubMed ID: 29308648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug permeability profiling using cell-free permeation tools: Overview and applications.
    Berben P; Bauer-Brandl A; Brandl M; Faller B; Flaten GE; Jacobsen AC; Brouwers J; Augustijns P
    Eur J Pharm Sci; 2018 Jul; 119():219-233. PubMed ID: 29660464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis for lipophilic drug transport through a model lipid membrane with membrane retention.
    Lee Y; Choi SQ
    Eur J Pharm Sci; 2019 Jun; 134():176-184. PubMed ID: 31022441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of lipid bilayer permeation of a series of ionisable drugs and their correlation with human transporter-independent intestinal permeability.
    Hermann KF; Neuhaus CS; Micallef V; Wagner B; Hatibovic M; Aschmann HE; Paech F; Alvarez-Sanchez R; Krämer SD; Belli S
    Eur J Pharm Sci; 2017 Jun; 104():150-161. PubMed ID: 28366650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic Artificial Membrane Permeability Assay over Franz Cell Apparatus Using BCS Model Drugs.
    de Souza Teixeira L; Vila Chagas T; Alonso A; Gonzalez-Alvarez I; Bermejo M; Polli J; Rezende KR
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33086670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
    Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
    Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Permeability Profiling Using the Novel Permeapad® 96-Well Plate.
    Jacobsen AC; Nielsen S; Brandl M; Bauer-Brandl A
    Pharm Res; 2020 May; 37(6):93. PubMed ID: 32394114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
    Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
    J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic passive permeability assay using nanoliter droplet interface lipid bilayers.
    Nisisako T; Portonovo SA; Schmidt JJ
    Analyst; 2013 Nov; 138(22):6793-800. PubMed ID: 24056299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a biomimetic phospholipid vesicle-based permeation assay for the estimation of intestinal drug permeability.
    Naderkhani E; Isaksson J; Ryzhakov A; Flaten GE
    J Pharm Sci; 2014 Jun; 103(6):1882-90. PubMed ID: 24665049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
    Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-Time Parallel Artificial Membrane Permeability Assay Based on Supramolecular Fluorescent Artificial Receptors.
    He S; Zhiti A; Barba-Bon A; Hennig A; Nau WM
    Front Chem; 2020; 8():597927. PubMed ID: 33330387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Label-free quantification of passive membrane permeability of cyclic peptides across lipid bilayers: penetration speed of cyclosporin A across lipid bilayers.
    Ono T; Tabata KV; Goto Y; Saito Y; Suga H; Noji H; Morimoto J; Sando S
    Chem Sci; 2023 Jan; 14(2):345-349. PubMed ID: 36687349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and evaluation of a modified PVPA barrier in comparison to Caco-2 cell monolayers for combined dissolution and permeation testing.
    Gantzsch SP; Kann B; Ofer-Glaessgen M; Loos P; Berchtold H; Balbach S; Eichinger T; Lehr CM; Schaefer UF; Windbergs M
    J Control Release; 2014 Feb; 175():79-86. PubMed ID: 24361370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeation prediction of M100240 using the parallel artificial membrane permeability assay.
    Hwang KK; Martin NE; Jiang L; Zhu C
    J Pharm Pharm Sci; 2003; 6(3):315-20. PubMed ID: 14738711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Intestinal Permeability of Small Molecule Drugs via Diffusion Motion on a Multidimensional Free Energy Surface.
    Shoji A; Kang C; Fujioka K; Rose JP; Sun R
    J Chem Theory Comput; 2022 Jan; 18(1):503-515. PubMed ID: 34851637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic Insights into Passive Membrane Permeability of Drug-like Molecules from a Weighted Ensemble of Trajectories.
    Zhang S; Thompson JP; Xia J; Bogetti AT; York F; Skillman AG; Chong LT; LeBard DN
    J Chem Inf Model; 2022 Apr; 62(8):1891-1904. PubMed ID: 35421313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants.
    Fischer SM; Flaten GE; Hagesæther E; Fricker G; Brandl M
    J Pharm Pharmacol; 2011 Aug; 63(8):1022-30. PubMed ID: 21718285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A liposomal fluorescence assay to study permeation kinetics of drug-like weak bases across the lipid bilayer.
    Eyer K; Paech F; Schuler F; Kuhn P; Kissner R; Belli S; Dittrich PS; Krämer SD
    J Control Release; 2014 Jan; 173():102-9. PubMed ID: 24211703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.